Trial Profile
A retrospective study investigating efficacy of abiraterone acetate in black versus white patients with metastatic castrate-resistant prostate cancer by analyzing prostate specific antigen response
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 08 Aug 2016 New trial record